ROS1 and non-small cell lung carcinoma: For example, although Swedish non-small cell lung cancer guidelines recommend NGS-based genomic testing for EGFR, KRAS, BRAF, ALK, NTRK, and ROS1, guidelines in Norway only include EGFR, ALK, and ROS1 [66].